Results 241 to 250 of about 1,187,054 (342)
Abstract Zanubrutinib is a next‐generation Bruton tyrosine kinase inhibitor approved for treating B‐cell malignancies. Two phase 1 studies evaluated a new 160‐mg zanubrutinib tablet versus 80‐mg capsules. In study BGB‐3111‐115 (n = 43), a randomized 3‐period crossover trial, relative bioavailability and food effects were assessed.
Bilal Tariq +5 more
wiley +1 more source
Carotid atherosclerotic plaque vulnerability assessment from angiography-derived radial wall strain validated by MRI. [PDF]
Wu Y +8 more
europepmc +1 more source
Role of carotid endarterectomy in asymptomatic carotid stenosis. A Veterans Administration Cooperative Study. [PDF]
openalex +1 more source
An asymptomatic papule on forearm
Vijay Adhe, Atul M Dongre
openaire +5 more sources
Abstract Asciminib is the first BCR::ABL1 inhibitor that Specifically Targets the ABL Myristoyl Pocket (STAMP) in patients with chronic myeloid leukemia. This phase 1, two‐treatment‐period, drug‐drug interaction study evaluated the effect of steady‐state asciminib on the pharmacokinetics of atorvastatin.
Matthias Hoch +9 more
wiley +1 more source
Idiopathic toe walkers: Do they need surgery? [PDF]
Bonnefoy-Mazure A +5 more
europepmc +1 more source
Abstract Bepirovirsen, an antisense oligonucleotide in development for the treatment of chronic hepatitis B virus (HBV) infection, is administered from glass vials as a subcutaneous (SC) injection by healthcare professionals (HCPs). A ready‐to‐use prefilled syringe (PFS) assembled with a safety syringe device (SSD) has been developed to make ...
Amir S. Youssef +15 more
wiley +1 more source
Treatment options for young patients with asymptomatic severe aortic stenosis: a multicenter retrospective cohort study. [PDF]
Mao Y +16 more
europepmc +1 more source

